
FDA approves biologic for treating psoriasis in those as young as 12
Adolescents with moderate to severe plaque psoriasis have a new option for treatment. On Oct. 13, 2017, the U.S. Food and Drug Administration (FDA) approved the use of Stelara (ustekinumab) for treating psoriasis in youth ages 12 and older. Stelara is a biologic (a drug made in a lab from living cells) that blocks proteins... Read More